Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › ppRB.sup.110 - nuclear phosphoprotein-the retinoblastoma susceptibility gene product

ppRB.sup.110 - nuclear phosphoprotein-the retinoblastoma susceptibility gene product

US Patent 6133424 · Granted Oct 17, 2000

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Isolated antibodies against interleukin-17 receptor B (IL-17RB) for cancer thera2020
RAD51 inhibitors and uses thereof2020
RAD51 inhibitors and uses thereof2019
Small molecule modifiers of the Hec1-Nek2 interaction in G2/M2017
Small molecule modifiers of the HEC1-NEK2 interaction in G2/M2016
Pharmaceutical compositions containing an indoyl isoquinoline containing compoun2015
Compositions and methods for disruption of BRCA2-Rad51 interaction2012
Methods and compounds for inhibiting Hec1 activity for the treatment of prolifer2012
Method of using an adenoviral vector encoding a retinoblastoma protein to treat 2006
Products and methods for controlling the suppression of the neoplastic phenotype2006
Method for producing retinoblastoma gene protein products2000
Retinoblastoma gene-cancer suppressor and regulator1999